All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
The 9B4 δ/αβTCR bound to CD1d–α-GalCer with very high affinity (Kd = 66 nM), even compared with the type I NKT15 αβTCR (Kd = 190 nM), and markedly higher than the 9C2 Vδ1+ γδTCR (Kd of 15 µM). This higher affinity of the 9B4 δ/αβTCR is partly caused by a slower dissociation rate (half-life of 24 s compared with 3.5 s for the NKT15 αβTCR). Thus, the 9B4 δ/αβTCR binds strongly to CD1d–α-GalCer and is highly sensitive to the type of CD1d-restricted lipid Ags presented.
There are currently no customer reviews or questions for Human anti-C50H99NO9 T cell receptor (9B4), pCDTCR1 (TCR-YC0257). Click the button below to contact us or submit your feedback about this product.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION